Historique du chiffre d'affaires, des bénéfices et des flux de trésorerie d'après les états financiers officiels.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The company home care cleaning and disinfecting products and laundry additives, skin sanitization and cleaning products, professional cleaning and disinfecting products, and professional food service products under the Clorox, Clorox2, Pine-Sol, Scentiva, Tilex, Liquid-Plumr, Formula 409, Purell, GOJO, CloroxPro, Clorox Healthcare, Hidden Valley, Poett, Clorinda, and Chux brands.
Voir les graphiques interactifs et les états complets → Modèle de valorisation (DCF) →
| Compte de résultat | TTM → 2026-06-30 | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 | 2016-06-30 | 2015-06-30 | 2014-06-30 | 2013-06-30 | 2012-06-30 | 2011-06-30 | 2010-06-30 | 2009-06-30 | 2008-06-30 | 2007-06-30 | 2006-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chiffre d'affaires total | $6.7B | $6.7B | $7.1B | $7.1B | $7.4B | $7.1B | $7.3B | $6.7B | $6.2B | $6.1B | $6.0B | $5.8B | $5.7B | $5.5B | $5.5B | $5.5B | $5.2B | $5.2B | $5.5B | $5.3B | $4.8B | $4.6B |
| Bénéfice brut | $2.8B | $2.8B | $3.2B | $3.0B | $2.9B | $2.5B | $3.2B | $3.1B | $2.7B | $2.7B | $2.7B | $2.6B | $2.5B | $2.4B | $2.4B | $2.3B | $2.3B | $2.3B | $2.3B | $2.2B | $2.1B | $2.0B |
| Marge brute % | 42.3% | 42.3% | 45.2% | 43.0% | 39.4% | 35.8% | 43.6% | 45.6% | 43.9% | 43.7% | 44.7% | 45.1% | 43.6% | 42.7% | 43.2% | 42.1% | 43.5% | 44.3% | 43.0% | 41.2% | 43.1% | 42.2% |
| Résultat opérationnel (EBIT) | $886M | $886M | $1.2B | $723M | $823M | $719M | $1.2B | $1.3B | $1.1B | $1.1B | $1.1B | $1.1B | $1.0B | $969M | $964M | $903M | $921M | $973M | $1.0B | $888M | $867M | $779M |
| Marge opérationnelle % | 13.2% | 13.2% | 16.6% | 10.2% | 11.1% | 10.1% | 16.7% | 18.8% | 17.8% | 18.4% | 18.7% | 18.3% | 17.7% | 17.6% | 17.4% | 16.5% | 17.6% | 18.6% | 18.7% | 16.8% | 17.9% | 16.8% |
| Résultat net | $587M | $587M | $810M | $280M | $149M | $462M | $710M | $939M | $820M | $823M | $701M | $648M | $580M | $558M | $572M | $541M | $557M | $603M | $537M | $461M | $501M | $444M |
| Marge nette % | 8.7% | 8.7% | 11.4% | 4.0% | 2.0% | 6.5% | 9.7% | 14.0% | 13.2% | 13.4% | 11.7% | 11.2% | 10.3% | 10.1% | 10.3% | 9.9% | 10.7% | 11.5% | 9.8% | 8.7% | 10.3% | 9.6% |
| EBITDA | — | — | $1.4B | $723M | $564M | $937M | $1.2B | $1.5B | $1.3B | $1.3B | $1.3B | $1.2B | $1.2B | $1.2B | $1.2B | $1.1B | $1.1B | $1.1B | $1.2B | $1.1B | $1.1B | $967M |
| Bénéfice par action (EPS) | — | $4.81 | $6.52 | $2.24 | $1.20 | $3.73 | $5.58 | $7.35 | $6.32 | $6.25 | $5.33 | $4.92 | $4.37 | $4.24 | $4.30 | $4.08 | $4.03 | $4.26 | $3.81 | $3.25 | $3.25 | $2.90 |
| Actions en circulation (M) | — | — | 124M | 125M | 124M | 124M | 127M | 128M | 130M | 132M | 132M | 132M | 133M | 132M | 133M | 133M | 138M | 142M | 141M | 142M | 154M | 153M |
Source : rapports publics de la société (SEC). Vérifiez sur SEC EDGAR avant de vous fier à tout chiffre.
Bilans, flux de trésorerie, données trimestrielles et ratios complets dans le visualiseur interactif de CLX. /companies/us/CLX
Les informations de ce site sont fournies à des fins éducatives et informatives uniquement ; elles ne constituent pas un conseil en investissement. Aucun objectif de cours ni recommandation n'est publié.
About TickerBase · Data methodology & sources · Privacy · Terms